Press release
Perjeta (Pertuzumab) Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Perjeta Pertuzumab
The escalation in breast cancer cases is set to fuel the expansion of the Perjeta (pertuzumab) market. Breast cancer denotes a condition where cancerous cells form in the breast tissue, often starting in the ducts or lobules. The surge in breast cancer cases can be credited to changes in lifestyle such as rising obesity and stagnant routines, alongside improved early identification through extensive screening programs. Perjeta (pertuzumab) is administered for the treatment of HER2-positive breast cancer by focusing on the HER2 receptor, and it is usually merged with trastuzumab and chemotherapy to boost treatment results. For instance, the Ray of Light Wales, a British not-for-profit charity, reported in October 2023 that the number of UK inhabitants surviving a breast cancer diagnosis is anticipated at 600,000 and is expected to swell to 1.2 million by 2030. Consequently, the growing incidence of breast cancer is powering the advancement of the herceptin biosimilars market.
Get Your Perjeta (Pertuzumab) Market Report Here:
https://www.thebusinessresearchcompany.com/report/perjeta-pertuzumab-global-market-report
What Is the projected market size and growth rate for the perjeta (pertuzumab) market?
In recent times, there has been significant growth in the size of the pertuzumab (Perjeta) market. Its growth is anticipated to continue, escalating from $935.92 million in 2024 to $1,084.80 million by 2025 with a compound annual growth rate (CAGR) of 15.9%. Factors contributing to this growth during the historic period include expanding adoption in the field of oncology, increased demand for antibody-drug conjugates (ADCs) and treatments that are less toxic and targeted, the rise of inorganic growth, as well as the surge in demand for individualized and targeted medicine.
Expected to see a sizable expansion in the next few years, the market for perjeta (pertuzumab) is projected to reach $1,932.66 million by 2029, representing a compound annual growth rate (CAGR) of 15.5%. The predicted growth for the forecast period is based on multiple factors including the escalating occurrence of breast cancer, growing interest in ADCs for blood-related cancers, increasing cancer rates and the existence of unmet medical needs, and the escalation of research and development efforts in the field of cancer immunotherapy by pharmaceutical companies. Key trends expected to manifest during the forecast period include the increased adoption of biosimilars in oncology, the development of generic versions and biosimilars, innovative drug formulation processes, advances in cancer immunotherapy research, and the rising prominence of combination therapies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19917&type=smp
What new trends are reshaping the perjeta (pertuzumab) market and its opportunities?
The prevailing trend in the Perjeta (pertuzumab) market aims at designing novel tech-oriented solutions like subcutaneous combination therapies to enhance patient prognosis and treatment accessibility. These therapies involve a mixture of two or more drugs in a single subcutaneous injection (inserted under the skin) to treat a specific condition. For example, in November 2023, Japan's Chugai Pharmaceutical Co., Ltd. introduced Phesgo, a subcutaneous combination treatment for HER2-positive breast cancer and advanced or recurrent HER2-positive colorectal cancer. This cutting-edge subcutaneous regimen fuses the monoclonal antibodies pertuzumab and trastuzumab with vorhyaluronidase alfa, facilitating administration in a quick 5 to 8 minutes, thus greatly minimizing the time in comparison to standard intravenous infusions. Phesgo is suggested for patients with advanced or recurring HER2-positive colorectal cancer, marking the first subcutaneous alternative for this condition.
What major market segments define the scope and growth of the perjeta (pertuzumab) market?
The perjeta (pertuzumab)market covered in this report is segmented -
1) By Type: Human source; Animal source
2) By Product: Monoclonal Antibody; Biologic Drug
3) By Indication: Early Breast Cancer; Metastatic Breast Cancer
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/Discount?id=19917&type=discount
Which region dominates the perjeta (pertuzumab) market?
North America was the largest region in the perjeta (pertuzumab) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the perjeta (pertuzumab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which key market leaders are driving the perjeta (pertuzumab) industry growth?
Major companies operating in the perjeta (pertuzumab) market include Roche Holding AG
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19917&type=smp
What Is Covered In The Perjeta (Pertuzumab) Global Market Report?
•Market Size Forecast: Examine the perjeta (pertuzumab) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the perjeta (pertuzumab) market for a structured understanding.
•Key Players Overview: Analyze major players in the perjeta (pertuzumab) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the perjeta (pertuzumab) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the perjeta (pertuzumab) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the perjeta (pertuzumab) market.
•Industry Challenges: Identify potential risks and obstacles affecting the perjeta (pertuzumab) market.
•Competitive Landscape: Review strategic developments in the perjeta (pertuzumab) market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Perjeta (Pertuzumab) Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3937638 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Perjeta
Perjeta Market Projected to Reach USD 7.13 Billion by 2034, Growing at a CAGR of …
Polaris Market Research announces the release of its latest research report titled, "Perjeta Market Size, Share, & Industry Analysis Report: By Type, By Product (Monoclonal Antibody and Generic Drug), By Indication, By Distribution Channel, and By Region - Market Forecast, 2025-2034."
The report analyzes the Perjeta market to register a CAGR of 5.3% from 2025 to 2034. The market was valued at USD 4.24 billion in 2024 and is projected…
Metastatic HER2 positive Breast Cancer Market: Analysis of Epidemiology, Pipelin …
Metastatic HER2 positive Breast Cancer emerging therapies such as HERCEPTIN, PERJETA, KADCYLA, ENHERTU, and others are expected to boost the Metastatic HER2 positive Breast Cancer Market in the upcoming years.
DelveInsight has launched a new report on "Metastatic HER2 positive Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Metastatic HER2 positive Breast Cancer, historical and forecasted epidemiology as well as the Metastatic HER2…
Transforming the Perjeta (Pertuzumab) Market in 2025: Rising Breast Cancer Incid …
What Is the Expected Size and Growth Rate of the Perjeta (Pertuzumab) Market?_x000D_
The market value of perjeta (pertuzumab) has seen quick expansion in the past few years. From $935.92 million in 2024, it's expected to increase to $1,084.80 million in 2025, with a compound annual growth rate (CAGR) of 15.9%. The rise in the historic phase can be tied down to an upsurge in its application within oncology, the growing…
Obsessive Compulsive Disorder (OCD) Market 2020-2025: Assessment and Growth Oppo …
All information provided in the report is derived from trusted industrial sources. Global Obsessive Compulsive Disorder (OCD) Market research reports finds market figures between 2020 and 2025. The market will exhibit remarkable CAGRs in the aforementioned period.
Global Obsessive Compulsive Disorder (OCD) Market Overview:
This report studies the Global Obsessive Compulsive Disorder (OCD) Market over the forecast period of 2020 to 2025. The Global Obsessive Compulsive Disorder (OCD) Market is expected to…
Exclusive Statistical Report on Immunomodulators Market: Industry to Observe Str …
Overview of Global Immunomodulators Market:
This report provides in-depth study of “Global Immunomodulators Market 2020” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Immunomodulators Market report also provides an in-depth survey of key players in the market organization.
Some of the major key factors driving the growth of the Global Immunomodulators Market are rapid growth in prevalence of autoimmune diseases, increasing cases of organ transplantation, growing prevalence…
Robust Growth Visible for Obsessive Compulsive Disorder (OCD) Market 2020-2025 | …
This report provides in-depth study on the current state of the Global Obsessive Compulsive Disorder (OCD) Market 2020-2025. Key players in the Global Obsessive Compulsive Disorder (OCD) Market have been identified through the secondary research and their market share has been determined through primary and secondary research. These include a study of annual and financial reports of top players and extensive interviews of leaders including CEOs, directors, and marketing executives.
Global…
